NEW
YORK, Nov. 29, 2024 /PRNewswire/ -- Report on
how AI is driving market transformation - The global cannabis
testing market size is estimated to grow by USD 2.05 billion from 2024-2028, according to
Technavio. The market is estimated to grow at a CAGR of
about 15.23% during the forecast period. Increasing use of
cannabis for medical purposes is driving market
growth, with a trend towards emergence of luxury cannabis
products. However, high cost of analytical products poses a
challenge. Key market players include Agilent Technologies Inc.,
AmSpec LLC, Analytical Center Biopharm GmbH, Bio Rad Laboratories
Inc., Danaher Corp., Digipath Inc., Eurofins Scientific SE, KNAUER
Wissenschaftliche Gerate GmbH, LabWare Inc., Medicinal Genomics
Corp., Merck KGaA, Mettler Toledo International Inc., PerkinElmer
Inc., Sartorius AG, SGS SA, Shimadzu Corp., Thermo Fisher
Scientific Inc., and Waters Corp..
AI-Powered Market Evolution Insights. Our
comprehensive market report ready with the latest trends, growth
opportunities, and strategic analysis- View Free Sample Report
PDF
Forecast
period
|
2024-2028
|
Base Year
|
2023
|
Historic
Data
|
2018 - 2022
|
Segment
Covered
|
Product (Consumables,
Instruments, and Software), End-user (Cannabis cultivators/growers,
Cannabis drug manufacturers, and Others), and Geography (North
America, Europe, Asia, and Rest of World (ROW))
|
Region
Covered
|
North America, Europe,
Asia, and Rest of World (ROW)
|
Key companies
profiled
|
Agilent Technologies
Inc., AmSpec LLC, Analytical Center Biopharm GmbH, Bio Rad
Laboratories Inc., Danaher Corp., Digipath Inc., Eurofins
Scientific SE, KNAUER Wissenschaftliche Gerate GmbH, LabWare Inc.,
Medicinal Genomics Corp., Merck KGaA, Mettler Toledo International
Inc., PerkinElmer Inc., Sartorius AG, SGS SA, Shimadzu Corp.,
Thermo Fisher Scientific Inc., and Waters Corp.
|
Key Market Trends Fueling Growth
The Cannabis testing market is experiencing significant growth
due to increasing demand for medical cannabis and stricter
regulatory standards. High costs associated with analytical testing
using instruments like Chromatography, Spectroscopy, and PCR
systems are driving the need for innovative testing solutions.
Potency testing, terpene profiling, pesticide screening, residual
solvent analysis, heavy metal testing, and microbial analysis are
essential services for cannabis testing labs. Cannabis testing
services and products cater to various matrices such as tinctures,
salves, edibles, vape oils, raw plant materials, transdermal
patches, and e-liquids. Strategic alliances between laboratories
and companies like Medicinal Genomics and service providers offer
testing procedure and testing equipment for cannabis
cultivators/growers and drug manufacturers. Regulatory standards
require testing for contaminants like pesticides, microbes, heavy
metals, and residual solvents to ensure consumer safety and product
quality. Contamination cases involving fungus, molds, and
insecticides have highlighted the importance of rigorous testing
procedures. The Farm Bill legalizing hemp cultivation in the US has
further boosted the market, with laboratories investing in novel
equipment and software for testing cannabidiol (CBD) and
tetrahydrocannabinol (THC) levels in various cannabis products. The
therapeutic potential of cannabis in treating conditions like
chemotherapy-induced nausea, chronic pain, and prescription
medications for AIDS patients, multiple sclerosis patients, and
glaucoma patients necessitates stringent testing
protocols.
In response to growing consumer demand for safer alternatives to
traditional cannabis consumption methods, a new market for luxury
cannabis products has emerged. These products offer controlled and
monitored quantities of cannabis, infused into edibles such as
cookies, chocolates, muffins, brownies, teas, and chewing gums. For
instance, Madame Munchie, a US-based company, produces
cannabis-infused macarons with 20mg of THC per serving. Their
offerings come in various flavors, catering to diverse tastes and
age groups (21 years and above). This market trend reflects a shift
towards more refined and health-conscious cannabis
consumption.
Insights on how AI is driving innovation,
efficiency, and market growth- Request Sample!
Market Challenges
- The cannabis testing market is experiencing significant growth
due to increasing demand for medical cannabis and stricter
regulatory standards. However, challenges persist for cannabis
testing labs, including the use of complex LIMS systems and high
testing costs. Medical cannabis patients, such as those undergoing
chemotherapy for cancer or living with conditions like AIDS, MS, or
glaucoma, rely on cannabis testing services for potency testing,
terpene profiling, pesticide screening, residual solvent analysis,
heavy metal testing, and microbial analysis. Cannabis testing
products and services are essential for cannabis
cultivators/growers and drug manufacturers to ensure product
quality and consumer safety. Novel equipment, software, and testing
solutions are driving innovation in this market. Strategic
alliances with companies like Medicinal Genomics and regulatory
bodies are crucial for addressing contamination cases caused by
fungus, molds, insecticides, mycotoxins, and other contaminants.
The Farm Bill and evolving regulatory landscape require cannabis
testing labs to adhere to stringent testing protocols for matrices
like tinctures, salves, edibles, vape oils, raw plant materials,
transdermal patches, e-liquids, and testing procedure and
equipment. Cannabinoids like Cannabidiol (CBD) and
Tetrahydrocannabinol (THC) are undergoing extensive research for
their therapeutic potential, adding to the market's growth.
- In the cannabis testing market, prominent vendors such as
Agilent Technologies, Merck, Perkin Elmer, Shimadzu, and Thermo
Fisher Scientific provide top-tier analytical solutions. These
products ensure accurate testing results for cannabis strains.
However, the high cost of these offerings poses a significant
challenge for cannabis testing laboratories, particularly medium
and small-scale facilities. Their budgets are often allocated
towards research and development of new cannabis strains, primarily
focusing on the extraction of various cannabinoids. Affordability
is a major concern, especially in developing countries, where
numerous small and medium-scale laboratories exist. Consequently,
these institutions opt for collaborations with other institutions
for proteomic research to mitigate the financial burden of
expensive testing equipment. Traditionally, large, complex, and
costly mass spectrometers were commonly found in university core
facilities.
Insights into how AI is reshaping industries and
driving growth- Download a Sample Report
Segment Overview
This cannabis testing market report extensively covers market
segmentation by
- Product
- 1.1 Consumables
- 1.2 Instruments
- 1.3 Software
- End-user
- 2.1 Cannabis cultivators/growers
- 2.2 Cannabis drug manufacturers
- 2.3 Others
- Geography
- 3.1 North America
- 3.2 Europe
- 3.3 Asia
- 3.4 Rest of World (ROW)
1.1 Consumables- The cannabis testing market
involves the use of reusable glassware, labware, solvents, and
reagents for the extraction and preparation of cannabis samples.
The sample preparation stage is vital as it eliminates impurities,
ensuring accurate testing results. Sigma-Aldrich, a Merck
subsidiary, is a leading vendor, providing consumables for
chromatography systems and mass spectrometers. Their Ascentis
chromatography columns, featuring fused-core particle technology,
offer high speed, efficiency, and compatibility with HPLC and LC-MS
instruments. This technology detects even sub-2um particulates,
operates at lower pressure, and increases resolving power. The
growing demand for precise testing results and innovative
consumables drives market growth during the forecast period.
Download complimentary Sample Report to
gain insights into AI's impact on market dynamics, emerging trends,
and future opportunities- including forecast (2024-2028) and
historic data (2018 - 2022)
Research Analysis
The Cannabis testing market has gained significant traction due
to the increasing demand for ensuring the safety and quality of
medical and recreational cannabis products. Laboratories use
advanced technologies like LIMS (Laboratory Information Management
Systems) to streamline testing processes and maintain records.
However, high testing costs remain a challenge for some players in
the market. Medical cannabis is used to alleviate symptoms of
various conditions, including nausea caused by chemotherapy, AIDS,
multiple sclerosis, and glaucoma. The therapeutic potential of
cannabis is vast, with potency testing services for cannabinoids
like Cannabidiol (CBD) gaining popularity. Contaminants, such as
microbes, pesticides, heavy metals, residual solvents,
insecticides, and mycotoxins, pose health risks and require
rigorous testing. Shelf life is another critical factor influencing
the market, with laboratories offering a range of service types
using equipment like Gas Chromatography to ensure product quality.
The Farm Bill legalizing hemp cultivation in the US has further
fueled market growth.
Market Research Overview
The cannabis testing market is a critical segment of the
burgeoning legal cannabis industry, focusing on ensuring product
safety and quality for medical and recreational consumers.
Analytical testing is essential for identifying potency, terpene
profiles, contaminants, and other essential components of cannabis
products. Laboratories utilize advanced analytical instruments such
as chromatography, spectroscopy, and PCR systems to analyze
cannabis samples. Medical cannabis patients, including those with
conditions like nausea from chemotherapy, AIDS, multiple sclerosis,
and glaucoma, rely on cannabis testing services and products for
consistent therapeutic potential. Potency testing, pesticide
screening, residual solvent analysis, heavy metal testing, and
microbial analysis are key testing services offered by cannabis
testing labs. The market for cannabis testing includes a variety of
products and services, such as testing solutions, testing services,
and analytical laboratories. These offerings cater to various
cannabis matrices, including tinctures, salves, edibles, vape oils,
raw plant materials, and novel equipment. Regulatory standards and
testing protocols are crucial for consumer safety and product
quality. Contaminants, such as microbes, pesticides, heavy metals,
and residual solvents, must be rigorously tested to ensure
compliance with industry regulations. Strategic alliances and
partnerships between companies, such as Medicinal Genomics and
laboratories like Botanacor and Agricor, contribute to the growth
of the cannabis testing market. Contamination cases involving
fungus, molds, insecticides, and mycotoxins have highlighted the
importance of testing procedures and equipment. The Farm Bill and
evolving regulatory frameworks have opened new opportunities for
cannabis testing services and products, catering to an increasing
demand for high-quality, safe, and consistent cannabis offerings.
Cannabidiol (CBD) and Tetrahydrocannabinol (THC) testing services
are particularly important for cannabis cultivators, growers, and
drug manufacturers. In conclusion, the cannabis testing market
plays a vital role in ensuring the safety, quality, and consistency
of cannabis products for medical and recreational consumers.
Advanced analytical instruments, testing services, and regulatory
compliance are key drivers of market growth.
Table of Contents:
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation
- Product
-
- Consumables
- Instruments
- Software
- End-user
-
- Cannabis Cultivators/growers
- Cannabis Drug Manufacturers
- Others
- Geography
-
- North America
- Europe
- Asia
- Rest Of World (ROW)
7 Customer Landscape
8 Geographic Landscape
9 Drivers, Challenges, and Trends
10 Company Landscape
11 Company Analysis
12 Appendix
About Technavio
Technavio is a leading global technology research and advisory
company. Their research and analysis focuses on emerging market
trends and provides actionable insights to help businesses identify
market opportunities and develop effective strategies to optimize
their market positions.
With over 500 specialized analysts, Technavio's report library
consists of more than 17,000 reports and counting, covering 800
technologies, spanning across 50 countries. Their client base
consists of enterprises of all sizes, including more than 100
Fortune 500 companies. This growing client base relies on
Technavio's comprehensive coverage, extensive research, and
actionable market insights to identify opportunities in existing
and potential markets and assess their competitive positions within
changing market scenarios.
Contacts
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/
View original content to download
multimedia:https://www.prnewswire.com/news-releases/cannabis-testing-market-to-grow-by-usd-2-05-billion-2024-2028-rising-medical-cannabis-use-boosts-revenue-report-highlights-ai-driven-market-evolution---technavio-302318453.html
SOURCE Technavio